These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 797150)

  • 1. [Augmented indication field for Convulex therapy (author's transl)].
    Gerstenbrand F; Harrer-Kuhnert G; Mamoli G
    Wien Klin Wochenschr; 1976 Dec; 88(23):760-2. PubMed ID: 797150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [MK-130, a new drug for the treatment of muscular hypertonia. Preliminary trial in 10 patients with spasticity of spinal origin].
    Molina-Negro P; Illingworth RA
    Union Med Can; 1971 Oct; 100(10):1947-51. PubMed ID: 5142212
    [No Abstract]   [Full Text] [Related]  

  • 3. [Sodium dantrolene (dantrium) in the treatment of neurogenic muscular spasm].
    Couto B; Figuereido HB; Araújo Leitão RE; Alvarenga H; Gomes Marleide M; Melo Reis CH
    Neurol Neurocir Psiquiatr; 1976; 17(4):213-21. PubMed ID: 1018726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Drug therapy of spinal spasms].
    Paeslack V
    Verh Dtsch Ges Inn Med; 1965; 71():665-7. PubMed ID: 5877681
    [No Abstract]   [Full Text] [Related]  

  • 5. [Use of beta-(p-clorophenil)-gamma-aminobutirric acid in the treatment of hemiplegic patients with hypertonius (author's transl)].
    Prati R; Soriani S
    Riv Patol Nerv Ment; 1974 Oct; 95(5):651-2. PubMed ID: 4470264
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of Dantrium on spasticity in paraplegic and tetraplegic patients (author's transl)].
    van Laere M; Leus P; Mastelinck C
    J Belge Med Phys Rehabil; 1978; 1(2):189-99. PubMed ID: 757420
    [No Abstract]   [Full Text] [Related]  

  • 7. [Further therapeutic possibilities with valproic acid (Convulex)].
    Auff E; Holzner F; Wessely P
    Wien Med Wochenschr; 1985 Sep; 135(17):421-3. PubMed ID: 3933186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of dantrolene sodium in the treatment of spasticity.
    Chipman M; Kaul S; Lambie M
    Dis Nerv Syst; 1974 Sep; 35(9):427-31. PubMed ID: 17894068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Studies on spasticity. II. Use of novocaine-alcohol infiltrations to reduce spasticity in the adult patient].
    Moya G; Campos Castelló J; Martínez Fuertes L
    Rev Clin Esp; 1969 Nov; 115(3):209-12. PubMed ID: 5405433
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effectiveness of ergenyl (dipropylacetate) in hypsarrhythmia].
    Rohmann E; Arndt R
    Kinderarztl Prax; 1976 Mar; 44(3):109-13. PubMed ID: 775170
    [No Abstract]   [Full Text] [Related]  

  • 11. [Dantrolene in juvenile spasticity: 3 months of daily observation].
    Berruti P
    Riv Neurol; 1979; 49(1):30-52. PubMed ID: 451397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgical treatment of spasticity by selective posterior rhizotomy: 30 years experience.
    Salame K; Ouaknine GE; Rochkind S; Constantini S; Razon N
    Isr Med Assoc J; 2003 Aug; 5(8):543-6. PubMed ID: 12929289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of spasticity in neurological disease by dantrolen-sodium (author's transl)].
    Chantraine A; van Ouwenaller C
    Nervenarzt; 1980 Jan; 51(1):50-4. PubMed ID: 7393365
    [No Abstract]   [Full Text] [Related]  

  • 14. [Electromyographic control of the effects of a muscle relaxant: LCB 29 in pyramidal hypertonia].
    Cadilhac J; Daprès G
    Rev Electroencephalogr Neurophysiol Clin; 1972; 2(2):153-8. PubMed ID: 4681591
    [No Abstract]   [Full Text] [Related]  

  • 15. A clinical study of intrathecal baclofen using a programmable pump for intractable spasticity.
    Guillaume D; Van Havenbergh A; Vloeberghs M; Vidal J; Roeste G
    Arch Phys Med Rehabil; 2005 Nov; 86(11):2165-71. PubMed ID: 16271565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A prognostic study of cryptogenic infantile spasms].
    Boulloche J; Dautreme P; Le Luyer B; Mallet E; Tron P
    Ann Pediatr (Paris); 1991 Feb; 38(2):71-4. PubMed ID: 1709342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [EEG characteristics of children with perinatal encephalopathy and juvenile cerebral palsy during the first two years].
    Fantalova VL; Semenova KA; Filina TF
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1974; 74(10):1477-85. PubMed ID: 4473878
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical study of dantrolene sodium in the treatment of spastic and dystonic syndromes].
    Fraioli B; Guglielmi G; Baldassarre L
    Riv Neurol; 1976; 46(4):333-50. PubMed ID: 1023344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of spasticity by phenol block.
    Rozin R; Magora F; Robin GC; Magora A
    Isr J Med Sci; 1970; 6(4):555-60. PubMed ID: 5536148
    [No Abstract]   [Full Text] [Related]  

  • 20. Botulinum neurotoxin type A injections reduce spasticity in mild to moderate hereditary spastic paraplegia--report of 19 cases.
    Hecht MJ; Stolze H; Auf dem Brinke M; Giess R; Treig T; Winterholler M; Wissel J;
    Mov Disord; 2008 Jan; 23(2):228-33. PubMed ID: 17999430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.